AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Duchenne Muscular Dystrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Arkansas Children's Hospital, Little Rock, Arkansas, United States

    Contact: Study coordinator (Amber Evans) · evansa17@archildrens.org · 501-364-2259
    Contact: Principal Investigator (Aravindhan Veerapandiyan, MD)
  • Stanford School of Medicine /Division of Neuromuscular Medicine, Palo Alto, California, United States

    Contact: Principal Investigator (Carolina Tesi-Rocha, MD)
  • Children's Hospital Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (Michele Yang) · Michele.Yang@childrenscolorado.org · 720-777-6895
    Contact: Study coordinator (Hannah Kleiner) · Hannah.Kleiner@childrenscolorado.org · 720-777-1377
    Contact: Principal Investigator (Michele Yang, MD)
  • University of Florida, Gainesville, Florida, United States

    Contact: Study coordinator (Melissa Lewis) · melissa.lewis@peds.ufl.edu · 352-273-8218
    Contact: Principal Investigator (Barry Byrne, MD)
  • Rare Disease Research, Atlanta, Georgia, United States

    Contact: Study coordinator (Lily Goggans) · lily.goggans@rarediseaseresearch.com · 470-600-9134
    Contact: Study coordinator (Maureen Ikpeoha) · maureen.ikpeoha@rarediseaseresearch.com · 470-666-1884
    Contact: Principal Investigator (Han Phan, MD)
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Nicole Geanous) · ngeanous@luriechildrens.org · 312-227-3019
    Contact: Principal Investigator (Nancy L Kuntz, MD)
  • University of Iowa, Iowa City, Iowa, United States

    Contact: Study coordinator (Laura Knosp) · laura-knosp@uiowa.edu · 319-384-6277
    Contact: Principal Investigator (Dimah Saade, MD)
  • University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

    Contact: Study coordinator (Tyler Mola) · tyler.mola@umassmed.edu · 978-503-9219
    Contact: Principal Investigator (Eleonora D'Ambrosio, MD)
  • Cincinnati Children's, Cincinnati, Ohio, United States

    Contact: Study coordinator (Angela Edmondson) · Angela.Edmondson@cchmc.org · 513-636-9285
    Contact: Principal Investigator (Cuixia Tian, MD)
  • Oregon Health & Science University, Portland, Oregon, United States

    Contact: Study coordinator (Beata Dyar) · dyar@ohsu.edu · 503-494-8216
    Contact: Principal Investigator (Erika Finanger, MD)
  • The University of Texas Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Elaine Most) · elaine.most@utsouthwestern.edu · 214-456-2463
    Contact: Principal Investigator (Susan Iannaccone, MD)
  • Children's Hospital of the King's Daughters, Norfolk, Virginia, United States

    Contact: Study coordinator (Erika Paradiso) · proud.research@chkd.org · 757-668-6981
    Contact: Principal Investigator (Crystal Proud, MD)
  • Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, United States

    Contact: Study coordinator (Falgun Patel) · Falgun.Patel@vcuhealth.org · (804) 827-9731
    Contact: Principal Investigator (Amy Harper, MD)
  • Alberta Children's Hospital, Calgary, Alberta, Canada

    Contact: Study coordinator (Israt Yasmeen, MBT) · Israt.Yasmeen@ahs.ca · 587-943-0851
    Contact: Principal Investigator (Jean Mah, MD)
  • BC Children's Hospital, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Nela Martic) · NMartic3@cw.bc.ca · 604-875-2345
    Contact: Principal Investigator (Kathryn Selby, MD)
  • Children's Hospital London Health Science Centre, London, Ontario, Canada

    Contact: Study coordinator (Rhiannon Hicks) · rhiannon.hicks@lhsc.on.ca · 519-685-8500
    Contact: Principal Investigator (Craig Campbell, MD)
  • Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada

    Contact: Study coordinator (Laura Thompson) · lathompson@cheo.on.ca · 613-737-7600
    Contact: Principal Investigator (Hugh McMillan, MD)